Lacuna appeared to be the VC, which was created in 1996. The main department of described VC is located in the Regensburg. The fund was located in Europe if to be more exact in Germany.
Among the most popular fund investment industries, there are Software, Medical. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight MerLion Pharma, Stokes Bio, Peak8 Partners.
The current fund was established by Werner Engelhardt.
The usual things for fund are deals in the range of 10 - 50 millions dollars. The high activity for fund was in 2008. The real fund results show that this VC is 0 percentage points less often commits exit comparing to other companies. This Lacuna works on 9 percentage points less the average amount of lead investments comparing to the other organizations. The fund is generally included in less than 2 deals every year.
The typical case for the fund is to invest in rounds with 2-3 participants. Despite the Lacuna, startups are often financed by Temasek Holdings, Novartis Venture Fund, JAFCO Asia. The meaningful sponsors for the fund in investment in the same round are Zu00fcrcher Kantonal Bank, Idinvest Partners, EDBI. In the next rounds fund is usually obtained by Tragara, Spartan Mobile, Sofinnova Partners.
Related Funds
Funds with similar focus
Fund Name | Location |
Aulas AMiGAS | Antioquia, Colombia, Medellín |
AWDK Invest | Capital Region of Denmark, Copenhagen, Denmark |
Axcel Partners | Maryland, Stevenson, United States |
Gepic Energy Development | China, Gansu, Lanzhou |
Greenwood Gulch Ventures | Colorado, Denver, United States |
Melbourne Accelerator Program | Australia, Melbourne, Victoria |
Singapura Finance | Central, Central Region, Singapore |
Sino-Ocean Capital | Beijing, Beijing, China |
US Renewables | California, Santa Monica, United States |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
$5M | 22 Feb 2008 | Boulder, Colorado, United States | |||
Auris Medical | $10M | 15 Feb 2008 | Basel, Basel-City, Switzerland | ||
Mocapay | $3M | 12 Jul 2007 | Denver, Colorado, United States | ||
MerLion Pharma | $30M | 01 Mar 2007 | Central |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
$5M | 22 Feb 2008 | Boulder, Colorado, United States | |||
Auris Medical | $10M | 15 Feb 2008 | Basel, Basel-City, Switzerland | ||
Mocapay | $3M | 12 Jul 2007 | Denver, Colorado, United States | ||
MerLion Pharma | $30M | 01 Mar 2007 | Central |